TARBP2 and neoplasm: Similarly, the systemic injection of 30 μg of synthetic TARBP2-dependent miR-143 or miR-145 showed a significant reduction of tumor volume, suggesting that CSC phenotypes of Ewing sarcoma correlate with the deregulation of TARBP2-dependent miRNA expression [81].